It’s not the first study that finds the lowly aspirin may protect against the deadliest kind of skin cancer, but it is one of the largest.
And it adds to a mounting pile of studies suggesting that cheap, common aspirin lowers the risk of many cancers — of the colon, breast, esophagus, stomach, prostate, bladder and ovary.
The new study, in the journal Cancer, looked at melanoma in 60,000 post-menopausal Caucasian women. (Light-skinned people have the highest risk of this cancer.) Over a 12-year period, women who took aspirin at least a couple of times a week had a 20 percent lower risk of developing melanoma.